| Literature DB >> 31490659 |
Shuang Bai1,2, Xiaoqian Ma1,2, Xiaoxiao Shi1,2, Jinjun Shao3, Tian Zhang1,2, Yajun Wang1,2, Yilong Cheng4, Peng Xue1,2, Yuejun Kang1,2, Zhigang Xu1,2.
Abstract
Low delivery efficiency and limited tumor penetration of nanoparticle-based drug delivery systems (DDSs), the two most concerned issues in tumor therapy, have been considered as the "Achilles' heel" for tumor treatment. In this study, we have designed a highly sensitive dual-redox-responsive prodrug-based starlike polymer β-CD-b-P(CPTGSH-co-CPTROS-co-OEGMA) (CPGR) for synergistic chemotherapy. The high glutathione (GSH) concentration and high reactive oxygen species (ROS) levels are in a dynamic equilibrium in the tumor microenvironment (TME) and could trigger the disintegration of CPGR micelles, which can promote the release of anticancer drug camptothecin (CPT) completely and intelligently. In order to verify the synergistic antitumor mechanism, two corresponding single-responsive β-CD-b-P(CPTGSH-co-OEGMA) (CPG) and β-CD-b-P(CPTROS-co-OEGMA) (CPR) were altogether prepared as contrast. Both in vitro and in vivo studies confirmed the enhanced anticancer activity of CPGR micelles in comparison of single responsive micelles. This work contributes to the orchestrated design of dual-redox-responsive DDSs for synergetic antitumor chemotherapy, which provides a good approach for the development of dual-redox-responsive nanomedicine.Entities:
Keywords: cancer therapy; delivery efficiency; dual-redox response; tumor microenvironment (TME); tumor penetration
Mesh:
Substances:
Year: 2019 PMID: 31490659 DOI: 10.1021/acsami.9b13214
Source DB: PubMed Journal: ACS Appl Mater Interfaces ISSN: 1944-8244 Impact factor: 9.229